Cargando…
A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties
Alternative splicing of the vascular endothelial growth factor A (VEGF-A) terminal exon generates two protein families with differing functions. Pro-angiogenic VEGF-A(xxx)a isoforms are produced via selection of the proximal 3′ splice site of the terminal exon. Use of an alternative distal splice si...
Autores principales: | Star, Eleanor, Stevens, Megan, Gooding, Clare, Smith, Christopher W. J., Li, Ling, Ayine, Monica Lamici, Harper, Steve J., Bates, David O., Oltean, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093282/ https://www.ncbi.nlm.nih.gov/pubmed/33941763 http://dx.doi.org/10.1038/s41389-021-00323-0 |
Ejemplares similares
-
The VEGF-A exon 8 splicing-sensitive fluorescent reporter mouse is a novel tool to assess the effects of splicing regulatory compounds in vivo
por: Stevens, M., et al.
Publicado: (2019) -
Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
por: Stevens, Megan, et al.
Publicado: (2018) -
VEGF‐A(165)b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF‐A splice isoforms from the kidney
por: Stevens, Megan, et al.
Publicado: (2017) -
Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis
por: Stevens, Megan, et al.
Publicado: (2019) -
SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing
por: Mavrou, Athina, et al.
Publicado: (2016)